Background
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are major health issues in COPD patients, and are important causes of hospital admission and mortality [
1‐
3]. AECOPD is diagnosed on clinical grounds, when specific symptoms (including dyspnea, increased sputum volume, and purulence) deteriorate beyond day-to-day variability, whereas severity is rated according to healthcare resource utilization [
4].
The observational study showed that the readmission for AECOPD within 30 days is associated with a progressive increased long-term risk of death [
5]. Nationwide study also demonstrated that 30-day readmissions after an AECOPD remain a major healthcare burden, associated with both patient and clinical factors (longer length of stay and discharge to a skilled nursing facility) [
6]. Most exacerbations appear to be associated with infective triggers including bacterial or viral causatives [
3]. Increased frequency of exacerbations is also significantly associated with forced expiratory volume in 1 s (FEV
1) decline [
7], and can thereby increase disease severity and mortality [
8].
Community-acquired pneumonia (CAP) is a frequently accompanied disease [
9] and is a valuable predictive factor of poor prognosis in AECOPD patients who require hospitalization [
10]. AECOPD patients with pneumonia were found to use non-invasive ventilation more frequently and remain hospitalized longer than those without pneumonia [
11]. Several studies have identified that old age, disease severity, and use of inhaled corticosteroids are predisposing factors better inducing CAP in COPD patients [
10,
12]. There is also another problem that readmission of AECOPD patients discharged after inpatient treatment. In fact, some studies explained that about 20% were readmitted due to AECOPD within 30 days after discharge [
13,
14].
The delta neutrophil index (DNI) is the immature granulocyte fraction determined by subtracting the fraction of mature polymorphonuclear leukocytes and reflects the number of immature neutrophils as a blood biomarker [
15]. DNI can easily be calculated and reported without an additional cost. Recently, systematic review and meta-analysis showed that the DNI has prognostic value in adults with sepsis and high DNI values tended to be associated with mortality in septic patients [
16]. Increased DNI can be useful to evaluate the prognosis of COPD patients, especially with pneumonia. However, many studies about on AECOPD patients who were readmitted after receiving inpatient treatment and discharge have not yet been published and there is no study of the relationship between DNI and AECOPD prognosis.
Therefore, we performed a retrospective cohort study to investigate the mortality rate of AECOPD patients with or without CAP who were readmitted within 6 months after discharge from the hospital. Then, we analyzed the cumulative survival rate according to serum DNI level and readmission duration of AECOPD patients.
Discussion
The most important point in this study was that AECOPD with CAP group who were readmitted ≤30 days and DNI ≥ 3.5% showed the lowest cumulative survival rate compared to the other groups. ROC curve demonstrated that DNI (≥ 3.5%) with readmission duration (≤ 30 days) can affect the mortality of AECOPD patients who were readmitted.
Currently, initial DNI with serum WBC and CRP which are commonly used markers is known to be useful for predicting inflammation and infection [
23]. DNI, the difference between the leukocyte differentials measured in cytochemical myeloperoxidase channel and those assayed in the nuclear lobularity channel, reflects the fraction of circulating immature granulocytes [
24,
25]. Previous study reported that granulocyte precursors less mature than bands can be a better predictor of infection than band neutrophil counts [
26]. The diagnostic value of DNI (reflecting the fraction of circulating immature granulocytes) was superior to WBC, absolute neutrophil count or other widely available laboratory markers for severe sepsis/septic shock [
25].
Many clinicians have studied the usefulness of blood biomarkers such as CRP and procalcitonin for early assessment of sepsis. Recently, systematic review and meta-analysis showed that the DNI has prognostic value in adults with sepsis and high DNI values tend to be associated with mortality in septic patients [
15]. Several studies have been reported to use DNI for the diagnosis or prognosis of other infectious diseases including pneumonia, pulmonary tuberculosis, and acute prostatitis [
23,
27,
28]. However, there are no reports on the usefulness of DNI in COPD patients. In our paper, we focused on the AECOPD patients who readmitted within 180 days of discharge.
The observational study showed that the readmission for AECOPD within 30 days is associated with a progressive increased long-term risk of death [
5]. In this study, ROC curve showed that DNI was a useful biologic marker for predicting the mortality rate of AECOPD in addition to readmission within 30 days. DNI levels were higher in AECOPD with CAP patients than without CAP. This indicates that DNI levels are associated with infection even in AECOPD. However, the mortality rate was the highest in patients readmitted within 30 days, suggesting that readmission within 30 days had a greater impact on prognosis than DNI level.
Readmission within 30 days and serum DNI level were significantly associated with the mortality of readmitted AECOPD patients when we analyzed the risk factors using multivariate analysis. And when the cut off value of DNI level is set to 3.5%, readmission duration (≤ 30 days) and serum DNI level (≥ 3.5%) have shown to be more useful in predicting mortality than readmission duration (≤ 30 days) and CAP in ROC curve analysis.
Unfortunately, there are no studies showing the usefulness of DNI in AECOPD patients so far and it was a problem to determine the cutoff value of DNI to predict prognosis. Previous study [
29] have shown that the DNI value of sepsis patients was 3.4% and our study confirmed that mean DNI value of AECOPD patients was 3.5%, so we set the cutoff value of DNI to 3.5%. Figure
3 also showed that AECOPD patients with readmission ≤30 days and DNI ≥ 3.5% showed significantly lower cumulative survival rate compared to other groups.
We considered why DNI levels are associated with mortality in AECOPD patients who were rehospitalized. Another study showed that DNI level at 72 h significantly correlated with mortality in patients with bacteremia [
30], and increased DNI values at the time admission were significantly associated with severe sepsis/septic shock and overt disseminated intravascular coagulation (DIC) and the elevation of DNI value preceded the onset of organ/circulatory failure [
25]. Our study showed that DNI levels were higher in AECOPD patients with CAP although we couldn’t confirm whether sepsis was associated with CAP. Patients with CAP are expected to have more patients with DIC, systemic inflammatory response syndrome or sepsis, which may have affected early readmission and mortality after discharge. However, there is no definitive study of the mechanism by which DNI affects mortality, and additional studies are needed.
We have some limitations in this study. First, the present study was performed in a single institution, selection bias may have influenced the significance of the present findings although the criteria of hospitalization were established, and thus a multicenter study is required to validate the results. Second, we did not accurately assess the patients with SIRS or sepsis in this study so could not clearly explain the reason for increased DNI in patients with CAP. In addition, there is no clear reason for why mortality is higher in the increased-DNI group in patients with early readmission and further research is needed. Third, DNI alone has weak predictive power against mortality in AUC curve and increases predictability when accompanied by early readmission in AECOPD patients. These results suggest that biologic markers such as DNI still have difficulties in predicting the mortality of AECOPD patients and should be considered with clinical factors such as early readmission.
However, this study is meaningful to confirm the higher mortality rate in the increased DNI group with early readmission among AECOPD patients who were readmitted.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.